Trial · NCT00819234
Adverse events840
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 840
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | nausea | Gastrointestinal disorders | Placebo - Stable | 1 | 31 | 1 |
| other | nausea | Gastrointestinal disorders | 360 mcg Pramlintide + 1.25mg Metreleptin - Stable | 3 | 35 | 3 |
| other | nausea | Gastrointestinal disorders | 360 mcg Pramlintide + 2.5 Metreleptin - Stable | 2 | 36 | 2 |
| other | nausea | Gastrointestinal disorders | 360 mcg Pramlintide + 5.0 Metreleptin - Stable | 5 | 28 | 5 |
| other | nausea | Gastrointestinal disorders | 360 mcg Pramlintide + 1.25 mg Metreleptin - Prior Mono+1.25 | 2 | 13 | 2 |
| other | nausea | Gastrointestinal disorders | 360 mcg Pramlintide + 2.5 mg Metreleptin - Prior Mono+2.5 | 1 | 14 | 1 |
| other | nausea | Gastrointestinal disorders | 360 mcg Pramlintide + 5.0 mg Metreleptin - Prior Mono+5.0 | 1 | 13 | 1 |
| other | nausea | Gastrointestinal disorders | 360 mcg Pramlintide + 5.0 mg Metreleptin - Prior Metre Mono | 11 | 29 | 13 |
| other | nausea | Gastrointestinal disorders | 360 mcg Pramlintide + 2.5 mg Metreleptin - Prior Lower Pram | 7 | 37 | 9 |
| other | nausea | Gastrointestinal disorders | 360 mcg Pramlintide + 5.0 mg Metreleptin - Prior Lower Pram | 8 | 37 | 12 |
| other | Upper respiratory tract infection | Infections and infestations | Placebo - Stable | 3 | 31 | 3 |
| other | Upper respiratory tract infection | Infections and infestations | 360 mcg Pramlintide + 1.25mg Metreleptin - Stable | 3 | 35 | 3 |
| other | Upper respiratory tract infection | Infections and infestations | 360 mcg Pramlintide + 2.5 Metreleptin - Stable | 5 | 36 | 8 |
| other | Upper respiratory tract infection | Infections and infestations | 360 mcg Pramlintide + 5.0 Metreleptin - Stable | 7 | 28 | 7 |
| other | Upper respiratory tract infection | Infections and infestations | 360 mcg Pramlintide + 1.25 mg Metreleptin - Prior Mono+1.25 | 3 | 13 | 4 |
| other | Upper respiratory tract infection | Infections and infestations | 360 mcg Pramlintide + 2.5 mg Metreleptin - Prior Mono+2.5 | 1 | 14 | 1 |
| other | Upper respiratory tract infection | Infections and infestations | 360 mcg Pramlintide + 5.0 mg Metreleptin - Prior Mono+5.0 | 0 | 13 | 0 |
| other | Upper respiratory tract infection | Infections and infestations | 360 mcg Pramlintide + 5.0 mg Metreleptin - Prior Metre Mono | 1 | 29 | 1 |
| other | Upper respiratory tract infection | Infections and infestations | 360 mcg Pramlintide + 2.5 mg Metreleptin - Prior Lower Pram | 4 | 37 | 4 |
| other | Upper respiratory tract infection | Infections and infestations | 360 mcg Pramlintide + 5.0 mg Metreleptin - Prior Lower Pram | 7 | 12 | 8 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00819234/events